You just read:

ARMO BioSciences' Immunotherapy AM0010 Receives Orphan Drug and Fast Track Designations from the U.S. FDA for the Treatment of Pancreatic Cancer

News provided by

ARMO BioSciences, Inc.

Nov 14, 2016, 07:00 ET